Skip to main content

Table 1 Correlation between TRIM62 Expression and Clinicopathologic Characteristics of Early-stage CC in Training Cohort and Validation Cohort

From: Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer

Clinicopathologic Variable Training Cohort Validation Cohort
  Total TRIM62 expression P-value Total TRIM62 expression P-value
   low High    low High  
Age(years)
42 61 40 21 0.388 44 26 18 0.973
  > 42 47 27 20   37 22 15  
FIGO stage
 Ia2 9 2 7 0.063 11 2 9 0.007 a
 Ib1 56 34 22   39 22 17  
 Ib2 18 12 6   14 9 5  
 IIa1 12 8 4   7 6 1  
 IIa2 13 11 2   10 9 1  
Tumor size(cm)
4 74 41 33 0.036 54 27 27 0.016
  > 4 34 26 8   27 21 6  
Pathologic types
 Squamous cell carcinoma 68 43 25 0.738 53 30 23 0.503
 Adenocarcinoma 40 24 16   28 18 10  
Differentiation grade
 Well 9 4 5 0.081 7 3 4 0.046 a
 Moderate 48 26 22   36 17 19  
 Poor 51 37 14   38 28 10  
Stromal invasion
  < 1/2 61 30 31 0.004 50 25 25 0.031
1/2 47 36 11   31 23 8  
 Lymphovascular space invasion
 Yes 14 12 2 0.050 11 8 3 0.511a
 No 94 55 39   70 40 30  
Pelvic-lymph node metastasis
 Yes 18 15 3 0.041 14 11 3 0.106
 No 90 52 38   67 37 30  
Vaginal involvement
 Yes 4 4 0 0.295a 3 3 0 0.267a
 No 104 63 41   78 45 33  
Parametrial infiltration
 Yes 3 3 0 0.287a 2 2 0 0.511a
 No 105 64 41   79 46 33  
Recurrence
 Yes 24 22 2 0.001 20 18 2 0.001
 No 84 45 39   61 30 31  
Vital status at follow-up
 Alive 86 47 39 0.002 61 30 31 0.001
 Dead 22 20 2   20 18 2  
  1. Abbreviations: FIGO the International Federation of Gynecology and Obstetrics
  2. a P-value from Fisher’s exact test; The bold number inside the table reflected P < 0.05